NKTR

NEKTAR THERAPEUTICS

CUSIP: 640268306

Market Cap
-
Sector
-
Institutional Owners
0
Institutional Value
-

About

Nektar Therapeutics is a biopharmaceutical company focused on discovering and developing novel medicines in the areas of cancer, auto-immune disease, and chronic pain. The company utilizes its advanced polymer conjugate chemistry platform to create new drug candidates designed to improve efficacy and safety. Nektar's pipeline includes both proprietary therapeutics and partnered programs with leading global pharmaceutical companies.

Institutional Holders

Loading...